| NCT ID | NCT01137825 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UNC Lineberger Comprehensive Cancer Center |
| Condition | Chronic Myeloproliferative Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2009-09 |
| Primary Completion | 2030-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2009-09 with a primary completion date of 2030-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.
Eligibility Criteria
DISEASE CHARACTERISTICS: * Patients must have an appointment at the North Carolina Cancer Hospital and agree to complete the Geriatric Assessment NOTE: Not all patients included in the registry will ultimately be diagnosed with cancer. Patients who complete a GA and are not diagnosed with cancer will remain in the database, but will be categorized into a separate group and will not have their medical records accessed. PATIENT CHARACTERISTICS: * Able to read and speak English PRIOR CONCURRENT THERAPY: * Not specified
Contact & Investigator
Hyman Muss, MD
PRINCIPAL INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT01137825 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Chronic Myeloproliferative Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01137825 currently recruiting?
Yes, NCT01137825 is actively recruiting participants. Contact the research team at knyrop@med.unc.edu for enrollment information.
Where is the NCT01137825 trial being conducted?
This trial is being conducted at Boone, United States, Chapel Hill, United States, Greenville, United States, Hendersonville, United States and 3 additional locations.
Who is sponsoring the NCT01137825 clinical trial?
NCT01137825 is sponsored by UNC Lineberger Comprehensive Cancer Center. The principal investigator is Hyman Muss, MD at UNC Lineberger Comprehensive Cancer Center. The trial plans to enroll 3,000 participants.